Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 28, 2026
Implementing Shared Decision-Making in Haemophilia Care: Best Practice Recommendations From a Western European Multi-Stakeholder Delphi Process
Donna Coffin, Robert Klamroth, Miguel Crato, et al.
The New England Journal of Medicine
|
December 12, 2017
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan, Liron Walsh, Will Lester, et al.
Cellular Immunology
|
January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
Sriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
The New England Journal of Medicine
|
January 2, 2020
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K John Pasi, Savita Rangarajan, Nina Mitchell, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 19, 2024
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy
Wolfgang Miesbach, Barbara Konkle, Pratima Chowdary, et al.
British Journal of Haematology
|
September 12, 2014
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates
Jerry Powell, Amy Shapiro, Margaret Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 11, 2021
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A
K John Pasi, Michael Laffan, Savita Rangarajan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 5, 2020
The World Federation of Hemophilia Annual Global Survey 1999-2018
Jeffrey S Stonebraker, Paula H B Bolton-Maggs, Mark Brooker, et al.
Thrombosis and Haemostasis
|
March 11, 2016
Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A
Johnny N Mahlangu, Margaret Ragni, Naresh Gupta, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 13, 2024
The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia
Vincenzo La Mura, Massimo Colombo, Graham R Foster, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 28, 2026
Implementing Shared Decision-Making in Haemophilia Care: Best Practice Recommendations From a Western European Multi-Stakeholder Delphi Process
Donna Coffin, Robert Klamroth, Miguel Crato, et al.
The New England Journal of Medicine
|
December 12, 2017
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan, Liron Walsh, Will Lester, et al.
Cellular Immunology
|
January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
Sriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
The New England Journal of Medicine
|
January 2, 2020
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K John Pasi, Savita Rangarajan, Nina Mitchell, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 19, 2024
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy
Wolfgang Miesbach, Barbara Konkle, Pratima Chowdary, et al.
British Journal of Haematology
|
September 12, 2014
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates
Jerry Powell, Amy Shapiro, Margaret Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 11, 2021
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A
K John Pasi, Michael Laffan, Savita Rangarajan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 5, 2020
The World Federation of Hemophilia Annual Global Survey 1999-2018
Jeffrey S Stonebraker, Paula H B Bolton-Maggs, Mark Brooker, et al.
Thrombosis and Haemostasis
|
March 11, 2016
Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A
Johnny N Mahlangu, Margaret Ragni, Naresh Gupta, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 13, 2024
The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia
Vincenzo La Mura, Massimo Colombo, Graham R Foster, et al.
Page
of 10